12 Month Price Forecast For MLSS
Distance to MLSS Price Forecasts
MLSS Price Momentum
๐ค Considering Milestone Scientific (MLSS)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Disclaimer: The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Data last updated: February 10, 2025 8:24 PM UTC
MLSS Analyst Ratings & Price Targets
Based on our analysis of 1 Wall Street analysts, MLSS has a consensus that is bullish. The median price target is $2.13, with forecasts ranging from $1.25 to $3.00. Currently, there are 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
With MLSS currently trading at $1.24, the median price forecast suggests a 71.4% upside. The most optimistic forecast comes from at , projecting a 141.9% upside, while Bruce Jackson at Benchmark provides the most conservative target, suggesting a 0.8% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MLSS Analyst Consensus
MLSS Price Target Range
Latest MLSS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MLSS.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Nov 20, 2024 | Benchmark | Bruce Jackson | Speculative Buy | Reiterates | $1.25 |
Oct 10, 2024 | Benchmark | Bruce Jackson | Speculative Buy | Initiates | $1.25 |
Stocks Similar to Milestone Scientific Inc
The following stocks are similar to Milestone Scientific based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Milestone Scientific Inc (MLSS) Financial Data
Milestone Scientific Inc has a market capitalization of $98.92M with a P/E ratio of -12.2x. The company generates $8.42M in trailing twelve-month revenue with a -54.9% profit margin.
Revenue growth is -36.3% quarter-over-quarter, while maintaining an operating margin of -96.0% and return on equity of -59.4%.
Valuation Metrics
Growth & Margins
Financial Health
๐ฅ Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.

Milestone Scientific Inc (MLSS) Company Overview
About Milestone Scientific Inc
Develops advanced injection technologies for healthcare.
Milestone Scientific Inc. generates revenue through the design, development, and commercialization of specialized medical devices and technologies, particularly in the dental and medical sectors. Its product offerings, such as the CompuDent and CompuFlo systems, are aimed at improving the efficiency and comfort of injection procedures, creating a niche market that addresses common pain points in medical and dental practices.
The company operates internationally, with a focus on the United States and China, and serves various medical fields including dentistry, plastic surgery, and dermatology. Incorporated in 1989 and based in Roseland, New Jersey, Milestone Scientific has established itself as a leader in innovative injection solutions.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
17
CEO
Mr. Jan Adriaan Haverhals
Country
United States
IPO Year
1995
Website
www.milestonescientific.comMilestone Scientific Inc (MLSS) Latest News & Analysis
Dr. Ilana Etelzon has adopted the CompuFloยฎ Epidural System in her practice after a positive clinical experience, indicating potential growth opportunities for the product.
The integration of the CompuFloยฎ Epidural System by Dr. Etelzon may signal growing clinical acceptance, potentially boosting sales and market confidence for the product's manufacturer.
Adoption of the CompuFloยฎ Epidural System is increasing, following a recent Medicare price assignment announcement.
Expanding adoption of the CompuFloยฎ Epidural System suggests growing market acceptance, potentially increasing revenue for the company and impacting stock performance positively.
Milestone Scientific Inc. (NYSE: MLSS) will have CEO Arjan Haverhals and Chairman Neal Goldman presenting at The Benchmark Company's investor conference on December 11, 2024.
The presentation at a prominent investor conference may enhance Milestone Scientific's visibility, potentially attracting new investment and affecting stock performance.
Milestone Scientific Secures Federal Supply Schedule (FSS) Approval on Contract for CompuFloยฎ Epidural System
2 months agoA new contract has been established, creating substantial market opportunities within federal healthcare systems.
The contract indicates potential revenue growth for companies involved in federal healthcare, enhancing market confidence and driving stock valuations in related sectors.
Milestone Scientific Inc. (NYSE: MLSS) held its Q3 2024 earnings call on November 15, 2024, featuring CEO Arjan Haverhals and VP Finance Keisha Harcum.
Milestone Scientific's Q3 earnings call reveals financial performance and strategic insights, impacting stock valuation and investor sentiment. Key executives will provide updates on growth and challenges.
Milestone Scientific Inc. (NYSE: MLSS) reported a 57% increase in international dental sales for Q3 2024 and is expanding the CompuFloยฎ Epidural System rollout following Medicare pricing updates.
A 57% rise in international dental sales and expansion of the CompuFloยฎ Epidural System signal strong growth potential and market demand for Milestone Scientific, positively impacting investor sentiment.
Frequently Asked Questions About MLSS Stock
What is Milestone Scientific Inc's (MLSS) stock forecast for 2025?
Based on our analysis of 1 Wall Street analysts, Milestone Scientific Inc (MLSS) has a median price target of $2.13. The highest price target is $3.00 and the lowest is $1.25.
Is MLSS stock a good investment in 2025?
According to current analyst ratings, MLSS has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.24. Always conduct your own research and consider your investment goals before making investment decisions.
What is the price prediction for MLSS stock?
Wall Street analysts predict MLSS stock could reach $2.13 in the next 12 months. This represents a 71.4% increase from the current price of $1.24. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Milestone Scientific Inc's business model?
Milestone Scientific Inc. generates revenue through the design, development, and commercialization of specialized medical devices and technologies, particularly in the dental and medical sectors. Its product offerings, such as the CompuDent and CompuFlo systems, are aimed at improving the efficiency and comfort of injection procedures, creating a niche market that addresses common pain points in medical and dental practices.
What is the highest forecasted price for MLSS Milestone Scientific Inc?
The highest price target for MLSS is $3.00 from at , which represents a 141.9% increase from the current price of $1.24.
What is the lowest forecasted price for MLSS Milestone Scientific Inc?
The lowest price target for MLSS is $1.25 from Bruce Jackson at Benchmark, which represents a 0.8% increase from the current price of $1.24.
What is the overall MLSS consensus from analysts for Milestone Scientific Inc?
The overall analyst consensus for MLSS is bullish. Out of 1 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $2.13.
How accurate are MLSS stock price projections?
Stock price projections, including those for Milestone Scientific Inc, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.